Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma

Journal of Neuroimmunology

Volumn 103, Issue 1, 2000, Pages 16-25

  Heimberger, Amy B ^a   Crotty, Laura E ^a   Archer, Gary E ^a   McLendon, Roger E ^a   Friedman, Allan ^a   Dranoff, Glenn ^b   Bigner, Darell D ^a   Sampson, John H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Central nervous system (CNS); Dendritic cells; Encephalomyelitis; Glioma

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CANCER IMMUNOTHERAPY; CELL LINE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DENDRITIC CELL; GLIOMA CELL; HOMOGENATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; BONE MARROW CELLS; BRAIN NEOPLASMS; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLIOMA; MICE; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VACCINATION;

EID: 0033957941     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00172-1     Document Type: Article

References (52)

1. Ashley D.M., Faiola B., Nair S., Hale L.P., Bigner D.D., Gilboa E. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. Journal of Experimental Medicine. 186:1997;1177-1182.
2. Ashley D.M., Sampson J.H., Archer G.E., Batra S.K., Bigner D.D., Hale L.P. A genetically modified allogeneic cellular vaccine generates MHC class I-restricted responses against tumor-associated antigens and protects against CNS tumors in vivo. J. Neuroimmunol. 78:1997;34-46.
3. Austyn J.M., Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:1981;805-815.
4. Bernard C.C.A. Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility. J. Immunogenet. 3:1976;263-274.
5. Bigner D.D., Pitts O.M., Wikstrand C.J. Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue. J. Neurosurg. 55:1981;32-42.
6. Bigner S.H., Humphrey P.A., Wong A.J., Vogelstein B., Mark J., Friedman H.S., Bigner D.D. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res. 50:1990;8017-8022.
7. Boczkowski D., Nair S.K., Snyder D., Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184:1996;465-472.
8. Bullard D.E., Gillespie G.Y., Mahaley M.S., Bigner D.D. Immunobiology of human gliomas. Semin. Oncol. 13:1986;94-109.
9. Coffman R.L., Weissman I.L. B220: a B cell-specific member of the T200 glycoprotein family. Nature. 289:1981;681-683.
10. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., Strober, W., 1991. Current Protocols in Immunology. Greene Publishing Associates, and Wiley, New York.
11. Danos O., Mulligan R.C. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. U. S. A. 85:1988;6460-6464.
12. Dialynas D.P., Wilde D.B., Marrack P., Pierres A., Wall K.A., Havran W., Otten G., Loken M.R., Pierres M., Kappler J., Fitch F.W. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol. Rev. 74:1983;29-56.
13. Duong T.T., Finkelman F.D., Singh B., Strejan G.H. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53:1994;101-107.
14. Fontana A., Hengartner H., de Tribolet N., Weber E. Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J. Immunol. 132:1984;1837-1844.
15. Gautam A.M., Glynn P. Lewis rat lymphoid dendritic cells can efficiently present homologous myelin basic protein to encephalitogenic lymphocytes. J. Neuroimmunol. 22:1989;113-121.
16. Gough N.M., Metcalf D., Gough J., Grail D., Dunn A.R. Structure and expression of the mRNA for murine granulocyte-macrophage colony stimulating factor. EMBO J. 4:1985;645-653.
17. Hathcock K.S., Laszlo G., Dickler H.B., Bradshaw J., Linsley P., Hodes R.J. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science. 262:1993;905-907.
18. Herrlinger U., Kramm C.M., Johnston K.M., Louis D.N., Finkelstein D., Reznikoff G., Dranoff G., Breakefield X.O., Yu J.S. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. Cancer Gene Ther. 4:1997;345-352.
19. Humphrey P.A., Wong A.J., Vogelstein B., Friedman H.S., Werner M.H., Bigner D.D., Bigner S.H. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res. 48:1988;2231-2238.
20. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1992;1693-1702.
21. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
22. Kurtzberg J., Hershfield M.S. Determinants of deoxyadenosine toxicity in hybrids between human T- and B-lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia. Cancer Res. 45:1985;1579-1586.
23. Levine S., Sowinski R. Experimental allergic encephalomyelitis in inbred and outbred mice. J. Immunol. 110:1973;139-143.
24. Lewinsohn D.M., Bargatze R.F., Butcher E.C. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J. Immunol. 138:1987;4313-4321.
25. Loken M.R., Stall A.M. Flow cytometry as an analytical and preparative tool in immunology. J. Immunol. Methods. 50:1982;R85-R112.
26. Medawar P.B. Immunity to homologous grafted skin: III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29:1948;58-69.
27. Mishima K., Nagane M., Lin H., Cavenee W.K., Huang H.-J.S. Expression of tumor-specific mutant epidermal growth factor receptor mediates glioma cell invasion in vivo. Proc. Am. Assoc. Cancer Res. 40:1999;519.
28. Morford T.A., Elliott L.H., Carlson S.L., Brooks W.H., Roszman T.L. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J. Immunol. 159:1997;4415-4425.
29. Nagane M., Coufal F., Lin H., Bogler O., Cavenee W.K., Huang H.J. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res. 56:1996;5079-5086.
30. Nair S.K., Boczkowski D., Snyder D., Gilboa E. Antigen-presenting cells pulsed with tumor unfractionated tumor-derived peptides are potent tumor vaccines. Eur. J. Immunol. 27:1997;589-597.
31. Nair S.K., Snyder D., Rouse B.T., Gilboa E. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int. J. Cancer. 70:1997;706-715.
32. Ozato K., Sachs D.H. Monoclonal antibodies to mouse MHC antigens: III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J. Immunol. 126:1981;317-321.
33. Paglia P., Chiodoni C., Rodolfo M., Colombo M.P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183:1996;317-322.
34. Porgador A., Gilboa E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182:1995;255-260.
35. Porgador A., Snyder D., Gilboa E. Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156:1996;2918-2926.
36. Raine C.S., Barnett L.B., Brown A., Behar T., McFarlin D.E. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab. Invest. 43:1980;150-157.
37. Razi-Wolf Z., Freeman G.J., Galvin F., Benacerraf B., Nadler L., Reiser H. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. U. S. A. 89:1992;4210-4214.
38. Reist C.J., Archer G.E., Kurpad S.N., Wikstrand C.J., Vaidyanathan G., Willingham M.C., Moscatello D.K., Wong A.J., Bigner D.D., Zalutsky M.R. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts. Cancer Res. 55:1995;4375-4382.
39. Sampson J.H., Archer G.E., Ashley D.M., Fuchs H.E., Hale L.P., Dranoff G., Bigner D.D. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system. Proc. Natl. Acad. Sci. U. S. A. 93:1996;10399-10404.
40. Sampson J.H., Ashley D.M., Archer G.E., Fuchs H.E., Dranoff G., Hale L.P., Bigner D.D. Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion. Neurosurgery. 41:1997;1365-1372.
41. Sampson, J.H., Bigner, D.D., Dranoff, G., 1998. Cytokine-based gene therapy for brain tumors. In: Chiocca, E.A., Breakefield, X.O. (Eds.), Gene Therapy for Neurological Disorders and Brain Tumors, 1st edn. Humana Press, New Jersey, pp. 231-294.
42. Sarmiento M., Glasebrook A.L., Fitch F.W. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:1980;2665-2672.
43. Serano R.D., Pegram C.N., Bigner D.D. Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA). Acta Neuropathol. 51:1980;53-64.
44. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271-296.
45. Steinman R.M., Nogueira N., Witmer M.D., Tydings J.D., Mellman I.S. Lymphokine enhances the expression and synthesis of Ia antigens on cultured mouse peritoneal macrophages. J. Exp. Med. 152:1980;1248-1261.
46. Wall K.A., Lorber M.I., Loken M.R., McClatchey S., Fitch F.W. Inhibition of proliferation of Mls- and Ia-reactive cloned T cells by a monoclonal antibody against a determinant shared by I-A and I-E. J. Immunol. 131:1983;1056-1064.
47. Wikstrand C.J., Bigner D.D. Surface antigens of human glioma cells shared with normal adult and fetal brain. Cancer Res. 39:1979;3235-3243.
48. Wikstrand C.J., Bigner D.D. Hyperimmunization of non-human primates with BCG-CW and cultured human glioma-derived cells. Production of reactive antisera and absence of EAE induction. J. Neuroimmunol. 1:1981;249-260.
49. Wikstrand C.J., Hale L.P., Batra S.K., Hill M.L., Humphrey P.A., Kurpad S.N., McLendon R.E., Moscatello D., Pegram C.N., Reist C.J., Traweek S.T., Wong A.J., Zalutsky M.R., Bigner D.D. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res. 55:1995;3140-3148.
50. Wikstrand C.J., McLendon R.E., Friedman A.H., Bigner D.D. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res. 57:1997;4130-4140.
51. Yu J.S., Burwick J.A., Dranoff G., Breakefield X.O. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells. Hum. Gene Ther. 8:1997;1065-1072.
52. Zitvogel L., Mayordomo J., Tjandrawan T., DeLeo A.B., Clarke M.R., Lotze M.T., Storkus W.J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokine. J. Exp. Med. 183:1996;87-97.